TSU has helped to create an effective analgesic without side effects
Scientists at the Institute for Problems of Chemical and Energetic Technologies (IPCET), SB RAS (Biysk), with the participation of TSU colleagues, have developed tiovyurtsin – a generic drug for the treatment of pain of various etiology. A feature of the new analgesic is having none of the side effects typical of steroid and non-steroidal anti-inflammatory drugs.
– As a raw material for the new drug we used glyoxal – a substance for which the industrial technology of synthesis was developed by chemists at Tomsk State University, – said Sergey Sysolyatin, the director of the IPCET SB RAS (a graduate of TSU’s Faculty of Chemistry). – High-energy compounds are also based on glyoxal. At the intermediate stage of synthesis, we are withdrawing a small portion of the substance, modifying it, and then obtaining a drug with excellent pharmacological characteristics.
